Lumida
/MPT
⌘K
MPT

MPT

MPT
$4.75USD-1.45%-0.07 today

MARKET CAP

2.8B

P/E (TTM)

FWD P/E

35.7x

DAY RANGE

$5 – $5

52W RANGE

$4
$14

AI Summary

Stalk
Buy NowMedium

MPT has broken out of its multi-month base into a Stage 2 advancing trend, confirmed by a momentum breakout above resistance. Despite the longer-term downtrend, the medium-term bias is bullish with price holding above flat-to-rising 9 and 21 EMAs and the 50-day average. Short-term conditions favor immediate entries as price tightly tracks the EMAs without signs of exhaustion. Pullbacks into the EMA support zone offer structurally valid entry opportunities now.

  • Plans to reach $1B annualized cash rent by end-2026 via rent stabilization.
  • Stock trading 40% below book value indicates potential undervaluation.
  • High leverage raises refinancing risks amid rising interest rates.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Medical Properties Trust, Inc. (NYSE: MPW) is a prominent real estate investment trust (REIT) that specializes in the acquisition and management of hospital facilities across both the United States and internationally. The company operates within the healthcare sector and has established itself as a significant player among healthcare REITs by focusing on sustainable rental cash flows and forging strategic leases with operating partners. Despite facing challenging market dynamics, MPT is navigating its growth trajectory amidst evolving healthcare demand, particularly as it aims to enhance its operational stability and income predictability.

Bull says

  • Plans to reach $1B annualized cash rent by end-2026 via rent stabilization.
  • Stock trading 40% below book value indicates potential undervaluation.
  • Dividend yield of 1.59% supports income for yield-focused investors.
  • Total portfolio EBITDARM coverage steady at 2.5x, reflecting tenant resilience.
  • 98% cash collections from re-tenanted hospitals boost near-term cash flow.
  • Strong liquidity and low price volatility provide downside support.

Bear says

  • High leverage raises refinancing risks amid rising interest rates.
  • Behavioral health segment underperforms due to US staffing shortages and NHS cuts.
  • Impaired cash rent from some transitioned tenants risks future cash flows.
  • Negative profitability and earnings yield metrics signal weak return generation.
  • Growth and analyst revisions trending down indicate stagnating outlook.
  • UK reimbursement cuts expose portfolio to regulatory and funding volatility.

Investment themes with MPT

Residential REITs +0.00%

Stable income from diversified rental housing portfolios

WELL · PSA · VTR

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 04-30-2026neutral

Transcript signals

Bull points

  • In Germany, Median delivered one of its best operating periods to date, supported by high occupancy, improving reimbursements, and sustained demand across orthopedics and other rehabilitation services.
  • We are confident in Median's ability to drive strong performance throughout 2026, given its scale and operating discipline.
  • Swiss Medical Network reinforced its leading position in the Swiss healthcare market through strategic acquisitions and expanded outpatient activities, focusing on disciplined capital deployment and the growth of their integrated care models.

Bear points

  • Historically, the National Health Service has reimbursed private providers for a substantial majority of these patients. But as we have reported on previous earnings updates, the NHS is significantly reducing that reimbursement. In reaction, Priory continues to prioritize service line optimization, cost management, and selective repositioning of certain facilities. We and Priory believe this to be a temporary condition, but the timing and degree of any recovery is unpredictable.
  • our behavioral health portfolio, which continues to navigate two entirely separate challenges in the U.S. and U.K. markets. While both markets continue to experience strong demand, in the U.S., providers are grappling with staffing shortages, and in the U.K., Demand is being dampened by funding pressures at the NHS.
  • they still are continuing not to collect as much cash as we and they would like to see.
Read full transcript analysis ›